Try our Advanced Search for more refined results

In re: Nexium Antitrust

  1. January 23, 2015

    Nexium Ruling Offers Road Map For Pay-For-Delay Classes

    The First Circuit's decision to uphold class certification in the Nexium pay-for-delay litigation despite the presence of some uninjured members in the group may be a hollow victory for the heartburn-drug purchasers after their recent loss at trial, but the ruling offers a boost for other plaintiffs as a bevy of antitrust class actions over pharmaceutical patent settlements forge ahead.

  2. January 22, 2015

    1st Circ. OKs Class Cert. In Nexium Pay-For-Delay Suit

    The First Circuit on Wednesday upheld the certification of a class of indirect purchasers of Nexium in pay-for-delay litigation over the heartburn drug, ruling that the presence of a few uninjured members in the class didn't prevent certification.

  3. December 22, 2014

    Nexium Buyers Call Appeal Dismissal Bid 'Gamesmanship'

    A group of Nexium buyers told the First Circuit on Friday that they didn't oppose AstraZeneca AB's bid to dismiss its class certification challenge in a pay-for-delay suit over the heartburn drug but warned that the drugmaker's claim that the suit was wrapped up was "mere gamesmanship."

  4. December 11, 2014

    AstraZeneca Drops 1st Circ. Row Over Nexium Class Cert.

    AstraZeneca AB and three generic-drug producers asked the First Circuit on Wednesday to dismiss their bid to nix class certification in a suit over alleged pay-for-delay deals regarding the heartburn drug Nexium, just five days after a jury handed a victory to the pharmaceutical giant in the lower part of the case.

  5. October 03, 2014

    Nexium Buyers Point To Dow Ruling To Support Class Cert.

    Plaintiffs fighting AstraZeneca PLC and other drug producers' attempt to nix their class certification in a suit over alleged pay-for-delay deals regarding the acid reflux medication Nexium sought to bolster their case Thursday by pointing the First Circuit to a recent ruling upholding certification for polyurethane purchasers.

  6. July 31, 2014

    1st Circ. Grills Attys On Nexium Pay-For-Delay Class Cert.

    A First Circuit panel voiced skepticism Thursday of AstraZeneca PLC's claim that a pay-for-delay case couldn't be certified as a class action if the class included any uninjured buyers, but the judges also repeatedly questioned how the plaintiffs planned to ensure that only the injured get damages.

  7. July 25, 2014

    1st Circ. Nexium Case May Ripple Beyond Pharma

    The First Circuit is set to hear arguments Thursday about whether a group of consumers, insurers and others who paid for Nexium can sue as a class over alleged pay-for-delay deals over the heartburn drug even though many of them may not have overpaid because of the patent settlements, in a case that could have implications beyond the pharmaceutical world.